// App-Quantinova.ai

PB2200 : Effects of Body Mass Index on the Human Plasma Proteome – Potential Drivers of Obesity-related Cardiovascular Disease?

Researchers

Presenter

  • L. Goudswaard

Principal Investigators

  • J.A. Bell

  • D.M. Hughes

  • K. Walter

  • N. Soranzo

  • A. Adam Butterworth

  • I. Hers

  • N.J. Timpson

Medical Centers

  • University of Bristol, School of Physiology, Pharmacology and Neuroscience, Bristol, United Kingdom

  • University of Bristol, Medical Research Council (MRC) Integrative Epidemiology Unit, Bristol, United Kingdom

  • Department of Population Health Sciences, Bristol Medical School, Bristol, United Kingdom

  • Wellcome Trust Sanger Institute, Cambridge, United Kingdom

  • University of Cambridge, NIHR Blood and Transplant Research Unit in Donor Health and Genomics, Department of Public Health and Primary Care, Cambridge, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Obesity

Biomarkers

  • Body mass index

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A